Home LiteratureArticle Details
PMID: 15608426 Published · ppublish English Comparative Study Journal Article

Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.

Advances in oto-rhino-laryngology ·Vol. 62 ·2005-00-00 ·Pages 161-72

Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL

Abstract

Apoptosis of circulating CD8+T cells seen in patients with squamous cell carcinoma of the head and neck (HNSCC) suggests a possibility of lymphocyte imbalance. Therefore, absolute numbers and percentages of T lymphocyte subsets were examined in the peripheral blood of patients with HNSCC and age-matched controls. Venous blood was obtained from 148 patients with HNSCC and 54 normal volunteers. Absolute numbers of CD3+, CD4+ and CD8+ T lymphocytes were determined using fluorobeads in a flow-cytometry-based technique. Percentages of T lymphocyte subsets were also evaluated by flow cytometry. The patients were grouped, at the time of blood draw (active vs. no evident disease, NED), type of therapy administered and the length of follow-up. Patients with HNSCC were found to have significantly lower absolute numbers of CD3+, CD4+and CD8+T cells than normal controls (NC). However, no differences in the percentages of T cell subsets between patients and NC were observed. Patients with active disease had significantly lower CD3+ and CD4+ T cell counts than those with NED. Patients with NED after surgery and radiotherapy had lower T cell counts than those treated by surgery alone. Patients who remained without evident disease for more than 2 years did not recover their T cell counts, and the T cell imbalance was evident many years after curative surgery. Patients with recurrent disease at the time of blood draw tended to have the lowest CD4+T cell counts. The TNM stage or site of the disease were not related to the absolute T cell count. Our data indicate that patients with HNSCC have altered lymphocyte homeostasis, which persists for months or years after curative therapies.

MeSH Terms
Adult Aged Aged, 80 and over Apoptosis/physiology Biomarkers/blood CD4 Lymphocyte Count CD4-CD8 Ratio Carcinoma, Squamous Cell/blood,physiopathology Case-Control Studies Female Head and Neck Neoplasms/blood,physiopathology Humans Lymphocyte Activation Lymphocyte Count Male Middle Aged Reference Values Sensitivity and Specificity Statistics, Nonparametric T-Lymphocyte Subsets/immunology
Chemicals
Biomarkers
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kuss I
University of Pittsburgh Cancer Institute, Pittsburgh, PaA 15213, USA.
Hathaway B
Ferris R L
Gooding W
Whiteside T L
Article Info
Journal
Advances in oto-rhino-laryngology
Abbr.
Adv Otorhinolaryngol
ISSN
0065-3071
Published
2005-00-00
Pages
161-72
Language
English
Region
Switzerland
NLM ID
0242534
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]